Commentary / Japan | Geoeconomic Briefing Feb 21, 2023
Why pharmaceuticals are a key issue in the ongoing U.S.-China conflict
Beijing has control over the chokepoints — active pharmaceutical ingredients and raw materials — of pharmaceutical supply chains.
